Efficacy and tolerability of brivaracetam monotherapy in childhood and juvenile absence epilepsy: An innovative adaptive trial design-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Efficacy and tolerability of brivaracetam monotherapy in childhood and juvenile absence epilepsy: An innovative adaptive trial design

Published:2022-08-04 Issue:4 Volume:7 Page:588-597
ISSN:2470-9239
Container-title:Epilepsia Open
language:en
Short-container-title:Epilepsia Open

Author:

Bast Thomas¹^ORCID,Schulz Anne‐Liv²,Floricel Florin²,Morita Diego³,Cleveland Jody M.³,Elshoff Jan‐Peer²^ORCID

Affiliation:

1. Epilepsy Center Kork Kehl Germany

2. UCB Pharma Monheim am Rhein Germany

3. UCB Pharma Morrisville North Carolina USA

Funder

UCB Pharma

Publisher

Wiley

Subject

Neurology (clinical),Neurology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/epi4.12628

Reference37 articles.

1. Proposal for Revised Classification of Epilepsies and Epileptic Syndromes.

2. A clinical study of syndromes of idiopathic (genetic) generalized epilepsy

3. Gabapentin in Naive Childhood Absence Epilepsy: Results From Two Double-Blind, Placebo-Controlled, Multicenter Studies

4. Lamictal (Lamotrigine) Monotherapy for Typical Absence Seizures in Children

5. Ethosuximide, Valproic Acid, and Lamotrigine in Childhood Absence Epilepsy

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Current state of the epilepsy drug and device pipeline;Epilepsia;2024-02-12

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP